After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

A scientist who pioneered the technology used to discover the biggest selling drug in the world, AbbVie’s Humira, was among a trio who received this year’s Nobel Prize in Chemistry.

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

>> good morning everyone. welcome to cnn this morning. it is saturday, march 8th 2025 i'm omar jimenez in atlanta. victor blackwell has the day off. we're going to start with new reports about a ...

>> good morning everyone. welcome to cnn this morning. it is saturday, march 8th, 2025. i'm i'm omar jimenez in atlanta. victor blackwell has the day off. we've got a lot to get to. we're going to ...

To sign up for Becker's Payer Issues E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may ...